Aditxt, Inc. Cash
Aditxt, Inc. (ADTX) had Cash of $268.85 thousand as of 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash and Cash Equivalent
us-gaap:Cash · last filed 2026-05-20
- 2026-03-31: Cash $268.85K.
- 2025-12-31: Cash $3.20M.
- 2024-12-31: Cash $833.03K.
- 2023-09-30: Cash $1.65M.
| Period end | Cash |
|---|---|
| 2026-03-31 | $268.85K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $3.20M 10-K · filed 2026-03-31 |
| 2024-12-31 | $833.03K 10-K · filed 2026-03-31 |
| 2023-09-30 | $1.65M 10-Q · filed 2023-11-14 |
| 2023-07-11 | $1.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $95.95K 10-Q · filed 2023-08-14 |
| 2023-04-18 | $10.00M 10-Q · filed 2023-11-14 |
| 2023-03-31 | $302.51K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.77M 10-K · filed 2023-04-17 |
| 2022-09-30 | $9.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $803.97K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $2.12M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.87M 10-K · filed 2022-03-31 |
| 2021-09-30 | $5.47M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $8.61M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $14.05M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $10.50M 10-K · filed 2021-03-25 |
| 2020-09-30 | $13.72M 10-Q · filed 2020-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |